Biomagnetics Diagnostics Corp. Stock

Stocks

BMGP

US09062Q1085

Advanced Medical Equipment & Technology

OTC Markets Traded
Delayed OTC Markets 11:50:26 2026-05-01 am EDT 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Biomagnetics Diagnostics Corp. -.--% -

Valuation: Biomagnetics Diagnostics Corp.

Market Cap 3.23M 2.8M 2.62M 2.4M 4.53M 308M 4.61M 30.87M 12.09M 153M 12.12M 11.85M 506M P/E 2009
-6.29x
P/E 2010 -22.9x
Enterprise Value 3.36M 2.92M 2.73M 2.51M 4.73M 321M 4.81M 32.19M 12.61M 160M 12.64M 12.36M 527M EV / Sales 2009
-
EV / Sales 2010 -
Free-Float
100%
Yield 2009 *
-
Yield 2010 -
5 years 0
Extreme 0
0
10 years 0
Extreme 0
0.01
Manager TitleAgeSince
Chief Executive Officer - 1997-02-25
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 277
+0.04%+2.47%+22.89%+4.56% 212B
+1.28%+0.04%-0.44%-23.64% 137B
+5.34%+4.57%-22.80%+19.87% 125B
+2.14%+4.77%-55.35%-6.29% 69.46B
+2.71%+6.17%+10.08%+10.20% 49.56B
+6.10%+9.98%-15.42%-19.36% 47.2B
+0.33%+0.71%+20.92%+11.05% 39.08B
-0.82%+1.20%+31.54%+28.91% 37.05B
-1.64%+6.81%+105.58%+9.19% 30.97B
Average +1.52%+2.87%+10.78%+3.83% 74.75B
Weighted average by Cap. +1.79%+2.80%+4.19%+1.54%

Financials

2009 2010
Net sales - -
Net income -1.17M -1.02M -951K -873K -1.65M -112M -1.67M -11.21M -4.39M -55.7M -4.4M -4.3M -184M -238K -207K -193K -178K -335K -22.71M -341K -2.28M -893K -11.33M -895K -875K -37.36M
Net Debt 126K 110K 102K 93.94K 177K 12.02M 180K 1.21M 473K 5.99M 474K 463K 19.77M 137K 119K 112K 102K 193K 13.1M 196K 1.32M 515K 6.53M 516K 505K 21.55M
Logo Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company’s diagnostics system focuses on real-time testing for the actual presence of the virus or toxin or disease itself and not for antibodies produced by the body's immune system which may take anywhere from weeks to months to appear. The Company’s products include High Throughput Screening - Magnetic Testing Platform (HTS-MTP) and Integrity Optical Biosensor (IOBS). Its HTS-MTP is designed to detect both qualitative chemical identification of the elements present in a substance and quantitative number of specific elements in a substance results from a single test. The Company triggered optical biosensor that is based on protein-receptor binding that brings two or more optically tagged receptors into close proximity using planar optical waveguides, thereby triggering fluorescence changes identified almost instantly by tiny on-board detectors.
Employees
2
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. BMGP Stock